CMS Proposes Changes to Medicare Payment Rules
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 5 days ago
0mins
Source: seekingalpha
- Drug Payment Reform: CMS proposes to change the payment structure for hospital outpatient departments and ambulatory surgical centers starting in 2027, particularly for 340B drugs, estimating a savings of approximately $1.15 billion for Original Medicare beneficiaries, indicating a positive impact on reducing patient costs.
- Taxpayer Savings: By aligning payments with documented acquisition costs, CMS anticipates saving taxpayers an additional estimated $4.55 billion in drug expenditures, leading to a total reduction of approximately $5.7 billion in drug spending, highlighting the fiscal significance of the policy.
- Imaging Service Payment Consistency: The proposal aims to eliminate payment discrepancies for imaging services like X-rays and MRIs between hospitals and outpatient clinics, with an expected $260 million reduction in expenditures in the first year, including $190 million in Part B savings and $70 million in reduced beneficiary premiums, enhancing fairness in healthcare services.
- Industry Impact Analysis: This policy change could have profound implications for the healthcare industry, particularly for companies like Tenet Healthcare, reflecting CMS's commitment to promoting transparency and equity in healthcare costs.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy THC?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on THC
Wall Street analysts forecast THC stock price to rise
10 Analyst Rating
10 Buy
0 Hold
0 Sell
Strong Buy
Current: 206.190
Low
229.00
Averages
242.89
High
260.00
Current: 206.190
Low
229.00
Averages
242.89
High
260.00
About THC
Tenet Healthcare Corporation is a diversified healthcare services company. The Company's segments include Hospital Operations and Services (Hospital Operations) and Ambulatory Care. The Hospital Operations segment consists of its acute care and specialty hospitals, imaging centers, ancillary outpatient facilities, micro-hospitals and physician practices. The Company's subsidiaries operate approximately 50 hospitals serving primarily urban and suburban communities in eight states. The Hospital Operations segment also includes around 132 outpatient facilities, including urgent care centers, imaging centers, off-campus hospital emergency department and micro hospitals. It also provides revenue cycle management and value based care services. Ambulatory Care segment, through its USPI Holding Company, Inc. subsidiary, holds ownership interests in approximately 533 ambulatory surgery centers, and 26 surgical hospitals in 37 states. It also operates a Global Business Center in the Philippines.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
CMS Proposes Changes to Medicare Payment Rules
- Drug Payment Reform: CMS proposes to change the payment structure for hospital outpatient departments and ambulatory surgical centers starting in 2027, particularly for 340B drugs, estimating a savings of approximately $1.15 billion for Original Medicare beneficiaries, indicating a positive impact on reducing patient costs.
- Taxpayer Savings: By aligning payments with documented acquisition costs, CMS anticipates saving taxpayers an additional estimated $4.55 billion in drug expenditures, leading to a total reduction of approximately $5.7 billion in drug spending, highlighting the fiscal significance of the policy.
- Imaging Service Payment Consistency: The proposal aims to eliminate payment discrepancies for imaging services like X-rays and MRIs between hospitals and outpatient clinics, with an expected $260 million reduction in expenditures in the first year, including $190 million in Part B savings and $70 million in reduced beneficiary premiums, enhancing fairness in healthcare services.
- Industry Impact Analysis: This policy change could have profound implications for the healthcare industry, particularly for companies like Tenet Healthcare, reflecting CMS's commitment to promoting transparency and equity in healthcare costs.
See More
Roblox and Tenet Healthcare Options Show High Trading Volume
- Roblox Options Volume: Today, Roblox Corp's options volume reached 83,304 contracts, equivalent to approximately 8.3 million shares, representing 71.3% of its average daily trading volume of 11.7 million shares over the past month, indicating strong market interest in the stock.
- High-Frequency Contracts: Notably, the $48 strike put option expiring on July 10, 2026, has seen 11,628 contracts traded today, representing about 1.2 million shares, suggesting an increased investor expectation for a decline in the stock price.
- Tenet Healthcare Options Activity: Tenet Healthcare Corp's options volume stands at 9,283 contracts, approximately 928,300 shares, accounting for 64.3% of its average daily trading volume of 1.4 million shares over the past month, reflecting ongoing market interest in the company.
- Bullish Call Options: Particularly, the $185 strike call option expiring on August 21, 2026, has recorded 4,587 contracts traded today, representing around 458,700 shares, indicating a bullish sentiment among investors regarding Tenet Healthcare's future performance.
See More
Tenet Fintech Group Adjusts Financial Disclosures Following OSC Review
- Financial Statement Restatement: Tenet Fintech Group has restated its financial statements for the year ended December 31, 2024, to correct deficiencies identified by the Ontario Securities Commission (OSC) during a review of continuous disclosure filings, thereby ensuring compliance and enhancing transparency.
- MD&A Updates: The company has refiled its Management Discussion and Analysis (MD&A) related to the 2024 financial statements and the Restated Interim Financial Statements to address critical issues such as revenue recognition and asset impairment, aiming to bolster investor confidence and improve future financing conditions.
- Compliance Risk Mitigation: This disclosure adjustment enables the company to apply for the revocation of the failure to file cease trade order issued by the OSC on May 7, 2025, indicating proactive efforts in compliance that may help restore market trust.
- Improved Future Outlook: Tenet Fintech Group believes that the enhancements in disclosure will significantly benefit existing and future shareholders, thereby strengthening its competitive position in the fintech sector.
See More
Tenet Fintech Closes Non-Brokered Private Placement
- Financing Size: Tenet Fintech has completed a non-brokered private placement issuing 55.2 million common shares at $0.05 each, raising a total of $2.76 million, which will be used to cover urgent short-term financial obligations such as rent and legal expenses.
- Trading Restrictions: Due to the failure-to-file cease trade order imposed on May 7, 2025, all newly issued securities will remain subject to trading restrictions until the order is fully lifted, impacting the company's liquidity and ability to raise further capital.
- Regulatory Dynamics: This financing follows the partial revocation order issued by the Ontario Securities Commission on May 25, 2026; while the partial revocation is a positive step, it does not guarantee a full revocation in the future, adding uncertainty for investors.
- Strategic Goals: Tenet is actively working to remedy the default that led to the cease trade order, and successfully lifting the order will enable the company to raise additional operational capital, thereby supporting its business development and market expansion plans.
See More
Profitable Companies May Not Last
- Warner Music Group Struggles: Warner Music Group (WMG) has seen only 8.7% annual revenue growth over the past five years, lagging behind its consumer discretionary peers, indicating a lack of competitive strength, and is expected to face deteriorating cash conversion capabilities, leading to declining investment value.
- Itron's Weak Growth: Itron (ITRI) reported a mere 1.4% annual revenue growth over the last two years, falling short of industrial sector standards, with projected sales growth of only 2.4% over the next 12 months reflecting weak demand, while a 6.5% return on capital indicates management's struggles in identifying profitable growth opportunities.
- Tenet Healthcare's Strong Performance: Tenet Healthcare (THC) has achieved a 16.8% annual earnings per share growth through share buybacks, outpacing revenue growth, and has increased its free cash flow margin by 12.7 percentage points over the past five years, enhancing its capacity for growth initiatives and share repurchases.
- Industry-Leading Capital Returns: Tenet Healthcare boasts a 22.5% return on capital, showcasing management's skill in identifying high-return investments, with returns continuing to grow as the company capitalizes on improving market opportunities.
See More
Tenet Healthcare Reports Strong Q1 2026 Earnings Amid Challenges
- Strong Financial Performance: Tenet Healthcare reported net operating revenues of $5.4 billion and adjusted EBITDA of $1.16 billion in Q1 2026, achieving an adjusted EBITDA margin of 21.6%, demonstrating resilience and profitability amid challenging market conditions.
- Robust Cash Flow Generation: The company generated $978 million in adjusted free cash flow during the first quarter, indicating strong operational efficiency and capital management capabilities, which are expected to support future investments and shareholder returns.
- Accelerated Acquisition Activity: Tenet invested $125 million to acquire 7 ambulatory surgical centers in Q1, reflecting its proactive strategy to expand business and market share, aimed at enhancing overall service capacity and competitive advantage.
- Stable Outlook: Management reaffirmed the full-year 2026 guidance, expecting consolidated adjusted EBITDA for Q2 to be 24% to 25% of the full-year target, indicating confidence in future performance despite challenges related to Medicaid and payer disputes.
See More
CMS Proposes Changes to Medicare Payment Rules
- Drug Payment Reform: CMS proposes to change the payment structure for hospital outpatient departments and ambulatory surgical centers starting in 2027, particularly for 340B drugs, estimating a savings of approximately $1.15 billion for Original Medicare beneficiaries, indicating a positive impact on reducing patient costs.
- Taxpayer Savings: By aligning payments with documented acquisition costs, CMS anticipates saving taxpayers an additional estimated $4.55 billion in drug expenditures, leading to a total reduction of approximately $5.7 billion in drug spending, highlighting the fiscal significance of the policy.
- Imaging Service Payment Consistency: The proposal aims to eliminate payment discrepancies for imaging services like X-rays and MRIs between hospitals and outpatient clinics, with an expected $260 million reduction in expenditures in the first year, including $190 million in Part B savings and $70 million in reduced beneficiary premiums, enhancing fairness in healthcare services.
- Industry Impact Analysis: This policy change could have profound implications for the healthcare industry, particularly for companies like Tenet Healthcare, reflecting CMS's commitment to promoting transparency and equity in healthcare costs.
See More
Roblox and Tenet Healthcare Options Show High Trading Volume
- Roblox Options Volume: Today, Roblox Corp's options volume reached 83,304 contracts, equivalent to approximately 8.3 million shares, representing 71.3% of its average daily trading volume of 11.7 million shares over the past month, indicating strong market interest in the stock.
- High-Frequency Contracts: Notably, the $48 strike put option expiring on July 10, 2026, has seen 11,628 contracts traded today, representing about 1.2 million shares, suggesting an increased investor expectation for a decline in the stock price.
- Tenet Healthcare Options Activity: Tenet Healthcare Corp's options volume stands at 9,283 contracts, approximately 928,300 shares, accounting for 64.3% of its average daily trading volume of 1.4 million shares over the past month, reflecting ongoing market interest in the company.
- Bullish Call Options: Particularly, the $185 strike call option expiring on August 21, 2026, has recorded 4,587 contracts traded today, representing around 458,700 shares, indicating a bullish sentiment among investors regarding Tenet Healthcare's future performance.
See More
Tenet Fintech Group Adjusts Financial Disclosures Following OSC Review
- Financial Statement Restatement: Tenet Fintech Group has restated its financial statements for the year ended December 31, 2024, to correct deficiencies identified by the Ontario Securities Commission (OSC) during a review of continuous disclosure filings, thereby ensuring compliance and enhancing transparency.
- MD&A Updates: The company has refiled its Management Discussion and Analysis (MD&A) related to the 2024 financial statements and the Restated Interim Financial Statements to address critical issues such as revenue recognition and asset impairment, aiming to bolster investor confidence and improve future financing conditions.
- Compliance Risk Mitigation: This disclosure adjustment enables the company to apply for the revocation of the failure to file cease trade order issued by the OSC on May 7, 2025, indicating proactive efforts in compliance that may help restore market trust.
- Improved Future Outlook: Tenet Fintech Group believes that the enhancements in disclosure will significantly benefit existing and future shareholders, thereby strengthening its competitive position in the fintech sector.
See More
Tenet Fintech Closes Non-Brokered Private Placement
- Financing Size: Tenet Fintech has completed a non-brokered private placement issuing 55.2 million common shares at $0.05 each, raising a total of $2.76 million, which will be used to cover urgent short-term financial obligations such as rent and legal expenses.
- Trading Restrictions: Due to the failure-to-file cease trade order imposed on May 7, 2025, all newly issued securities will remain subject to trading restrictions until the order is fully lifted, impacting the company's liquidity and ability to raise further capital.
- Regulatory Dynamics: This financing follows the partial revocation order issued by the Ontario Securities Commission on May 25, 2026; while the partial revocation is a positive step, it does not guarantee a full revocation in the future, adding uncertainty for investors.
- Strategic Goals: Tenet is actively working to remedy the default that led to the cease trade order, and successfully lifting the order will enable the company to raise additional operational capital, thereby supporting its business development and market expansion plans.
See More
Profitable Companies May Not Last
- Warner Music Group Struggles: Warner Music Group (WMG) has seen only 8.7% annual revenue growth over the past five years, lagging behind its consumer discretionary peers, indicating a lack of competitive strength, and is expected to face deteriorating cash conversion capabilities, leading to declining investment value.
- Itron's Weak Growth: Itron (ITRI) reported a mere 1.4% annual revenue growth over the last two years, falling short of industrial sector standards, with projected sales growth of only 2.4% over the next 12 months reflecting weak demand, while a 6.5% return on capital indicates management's struggles in identifying profitable growth opportunities.
- Tenet Healthcare's Strong Performance: Tenet Healthcare (THC) has achieved a 16.8% annual earnings per share growth through share buybacks, outpacing revenue growth, and has increased its free cash flow margin by 12.7 percentage points over the past five years, enhancing its capacity for growth initiatives and share repurchases.
- Industry-Leading Capital Returns: Tenet Healthcare boasts a 22.5% return on capital, showcasing management's skill in identifying high-return investments, with returns continuing to grow as the company capitalizes on improving market opportunities.
See More
Tenet Healthcare Reports Strong Q1 2026 Earnings Amid Challenges
- Strong Financial Performance: Tenet Healthcare reported net operating revenues of $5.4 billion and adjusted EBITDA of $1.16 billion in Q1 2026, achieving an adjusted EBITDA margin of 21.6%, demonstrating resilience and profitability amid challenging market conditions.
- Robust Cash Flow Generation: The company generated $978 million in adjusted free cash flow during the first quarter, indicating strong operational efficiency and capital management capabilities, which are expected to support future investments and shareholder returns.
- Accelerated Acquisition Activity: Tenet invested $125 million to acquire 7 ambulatory surgical centers in Q1, reflecting its proactive strategy to expand business and market share, aimed at enhancing overall service capacity and competitive advantage.
- Stable Outlook: Management reaffirmed the full-year 2026 guidance, expecting consolidated adjusted EBITDA for Q2 to be 24% to 25% of the full-year target, indicating confidence in future performance despite challenges related to Medicaid and payer disputes.
See More
